Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous TumorsYu Guo, Xiaowu Dong, Lu Yang et al.|Advanced Science|2024Cited by 34
Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemiaJingyu Zhang, Jinxin Che, Haiting Duan et al.|European Journal of Medicinal Chemistry|2023Cited by 14
Discovery of a New and Selective HPK1 PROTAC for Enhancing Tumor Immunotherapy through Eliminating GLK DegradationMingfei Wu, Xiaowu Dong, Xinfei Mao et al.|Journal of Medicinal Chemistry|2025Cited by 6